Branched-chain amino acid and cancer: metabolism, immune microenvironment and therapeutic targets

被引:0
作者
Xiong, Hao [1 ,2 ]
Liu, Ruiqi [4 ]
Xu, Keke [1 ,2 ]
Chen, Xiaoyan [1 ]
Huang, Luanluan [1 ]
Shou, Yiyi [1 ]
Huang, Yumei [3 ]
Sheng, Hailong [1 ]
Lu, Yanwei [1 ]
Zhang, Haibo [1 ]
机构
[1] Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Affiliated Peoples Hosp, Dept Radiat Oncol,Canc Ctr, Hangzhou, Zhejiang, Peoples R China
[2] Hangzhou Med Coll, Sch Basic Med Sci & Forens Med, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Prov Peoples Hosp, Hangzhou Med Coll, Affiliated Peoples Hosp, Dept Med Oncol,Canc Ctr, Hangzhou, Zhejiang, Peoples R China
[4] Tongde Hosp Zhejiang Prov, Dept Pathol, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
BCAA; Metabolic reprogramming; BCAT; Cancer; mTOR; GLUTAMIC-ACID; COPPER(II); PATHWAY; ENZYMES; LIGAND; BCKDK; BCAT1;
D O I
10.1186/s12967-025-06664-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cancer is one of the major diseases threatening human health in the world. According to the latest global cancer statistics from the International Agency for Research on Cancer (IARC), there were approximately 20 million new cancer cases and 10 million cancer deaths worldwide. Amidst this global health concern, branched chain amino acids have emerged as key players, playing an important role in the occurrence and development of cancer. In certain malignancies like colorectal cancer, the average level of BCAA in tumor tissues is twice that in normal tissues. BCAA metabolism is intricately associated with the progression of multiple tumors and is modulated by diverse enzymes, including BCAT, BCKDH, and BCKDK. The metabolism of BCAA involves multiple enzymes and biochemical processes via signaling pathways such as PI3K/AKT/mTOR and AMPK/mTOR, etc. In addition, mTOR inhibitors show potential value in cancer treatment by regulating the metabolism and signaling pathways of tumor cells, which provides a new direction for anticancer efforts. Simultaneously, BCAAs are closely associated with tumor immunity, including NK cells, CD4+ T cells, and CD8+ T cells. At present, the research on BCAA metabolism and related enzymes and signaling pathways is still in progress, aiming at identifying new targets and ideas for cancer therapy, and combined therapy will become an important trend in the future. In this review, we discuss the role and mechanisms of BCAA metabolism in human cancer.
引用
收藏
页数:16
相关论文
共 111 条
[1]   Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson's disease [J].
Acar, Yasemin ;
Agagunduz, Duygu ;
De Cicco, Paola ;
Capasso, Raffaele .
BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
[2]   Probiotics, Live Biotherapeutic Products (LBPs), and Gut-Brain Axis Related Psychological Conditions: Implications for Research and Dietetics [J].
Agagunduz, Duygu ;
Celik, Elif ;
Cemali, Ozge ;
Bingol, Feray Gencer ;
Ozenir, Ciler ;
Ozogul, Fatih ;
Capasso, Raffaele .
PROBIOTICS AND ANTIMICROBIAL PROTEINS, 2023, 15 (04) :1014-1031
[3]   Understanding the role of the gut microbiome in gastrointestinal cancer: A review [J].
Agagunduz, Duygu ;
Cocozza, Ermelinda ;
Cemali, Oezge ;
Bayazit, Ayse Derya ;
Nani, Maria Francesca ;
Cerqua, Ida ;
Morgillo, Floriana ;
Saygili, Suna Karadeniz ;
Berni Canani, Roberto ;
Amero, Paola ;
Capasso, Raffaele .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[4]   The need to establish and recognize the field of clinical laboratory science (CLS) as an essential field in advancing clinical goals [J].
Aghaei, Mojtaba ;
Khademi, Reyhane ;
Bahreiny, Seyed Sobhan ;
Saki, Najmaldin .
HEALTH SCIENCE REPORTS, 2024, 7 (08)
[5]  
Aghapour SA., 2024, Iran J Blood Cancer, V16, P84, DOI DOI 10.61186/IJBC.16.2.84
[6]   Enantioselective toxicity and carcinogenesis [J].
Ali, Imran ;
Aboul-Enein, Hassan Y. ;
Ghanem, Ashraf .
CURRENT PHARMACEUTICAL ANALYSIS, 2005, 1 (01) :109-125
[7]   Progress in Polymeric Nano-Medicines for Theranostic Cancer Treatment [J].
Ali, Imran ;
Alsehli, Mosa ;
Scotti, Luciana ;
Scotti, Marcus Tullius ;
Tsai, Shang-Ting ;
Yu, Ruei-Siang ;
Hsieh, Ming Fa ;
Chen, Jung-Chih .
POLYMERS, 2020, 12 (03)
[8]   Anticancer metallodrugs of glutamic acid sulphonamides: in silico, DNA binding, hemolysis and anticancer studies [J].
Ali, Imran ;
Wani, Waseem A. ;
Saleem, Kishwar ;
Hsieh, Ming-Fa .
RSC ADVANCES, 2014, 4 (56) :29629-29641
[9]   Thalidomide: A Banned Drug Resurged into Future Anticancer Drug [J].
Ali, Imran ;
Wani, Waseem A. ;
Saleem, Kishwar ;
Haque, Ashanul .
CURRENT DRUG THERAPY, 2012, 7 (01) :13-23
[10]  
Ali I, 2013, FUTURE MED CHEM, V5, P961, DOI [10.4155/FMC.13.62, 10.4155/fmc.13.62]